Randomized Prospective Trial of Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer

Principal Investigator

Kari Rosenkranz

Study Number

F20073

Summary

This prospective, multicenter, 1:1 randomized, controlled trial is designed to evaluate the safety and effectiveness of the Breast Cancer Locator (BCL) in subjects with non-palpable invasive breast cancer or ductal carcinoma in situ (DCIS). Subjects will be randomized to breast conserving surgery (BCS) utilizing either the BCL or wire localization (WL) to guide surgery.

Phase

N/A

Contact

Lauren Sinks

Available at the following location(s)

• Lebanon
• Keene

View more details at ClinicalTrials.gov

Do you need help with some of the labels on this page?
Read our glossary of terms